| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Frauke Förger | |
| Monika Østensen | |||
| P2860 | cites work | Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn | Q28176522 |
| Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis | Q28194515 | ||
| Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura | Q28200119 | ||
| Anti-inflammatory and immunosuppressive drugs and reproduction | Q28218219 | ||
| Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data | Q31044246 | ||
| Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child | Q32161554 | ||
| Hydroxychloroquine in lupus pregnancy | Q33373145 | ||
| Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development | Q33380175 | ||
| Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis | Q33389401 | ||
| Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients | Q33457785 | ||
| Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases | Q33579097 | ||
| Folic acid antagonists during pregnancy and the risk of birth defects. | Q33926560 | ||
| Low dose weekly methotrexate in early pregnancy. A case series and review of the literature | Q34012302 | ||
| Teratogen update: azathioprine and 6-mercaptopurine. | Q34124884 | ||
| Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study | Q34512958 | ||
| Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease | Q34632049 | ||
| Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother | Q34740297 | ||
| A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments | Q35553311 | ||
| Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease | Q36072580 | ||
| Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy | Q36678548 | ||
| Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature | Q37342365 | ||
| A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database | Q37365369 | ||
| Adult and two children with fetal methotrexate syndrome | Q39465825 | ||
| Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects | Q40537662 | ||
| Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy | Q40844061 | ||
| Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs | Q41441085 | ||
| Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group | Q41915008 | ||
| Evidence of transplacental passage of hydroxychloroquine in humans | Q41917690 | ||
| THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE. | Q41943335 | ||
| Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide | Q42025822 | ||
| Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome | Q43048618 | ||
| Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study | Q43433825 | ||
| Population-based case control study of the safety of sulfasalazine use during pregnancy | Q43563783 | ||
| Developing drugs to decrease the toxicity of chemotherapy | Q43675480 | ||
| Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases | Q43743058 | ||
| The effect of nonsteroidal anti-inflammatory drugs on ovulation: a prospective, randomized clinical trial | Q43796281 | ||
| A prospective randomized safety trial of celecoxib for treatment of preterm labor | Q44141447 | ||
| The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes | Q44300636 | ||
| No effects of bisphosphonates on the human fetus | Q44471962 | ||
| Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period | Q44506234 | ||
| Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn | Q44677102 | ||
| Safety of rituximab therapy during the first trimester of pregnancy: a case history | Q44847719 | ||
| The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients | Q44847829 | ||
| Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats | Q46290882 | ||
| Maternal corticosteroid use and orofacial clefts | Q46366324 | ||
| Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis | Q46777592 | ||
| Efficacy and safety of a combined rituximab chemotherapy during pregnancy. | Q49237933 | ||
| Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. | Q50545337 | ||
| Therapy: are TNF inhibitors safe in pregnancy? | Q51741580 | ||
| Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. | Q51752635 | ||
| Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. | Q52931732 | ||
| Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. | Q53239672 | ||
| Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy | Q56446825 | ||
| Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t | Q56966479 | ||
| Pregnancy outcome following in utero exposure to bisphosphonates | Q57215166 | ||
| Pregnancy outcome in women who were exposed to anti–tumor necrosis factor agents: Results from a national population register | Q57751365 | ||
| Prenatal exposure to prednisone in humans and animals retards intrauterine growth | Q67399513 | ||
| Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment | Q68139494 | ||
| The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor | Q69509140 | ||
| Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents | Q72109216 | ||
| Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome | Q72444051 | ||
| Long-term nephrotoxicity after exposure to cyclosporine in utero | Q72835696 | ||
| Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies | Q73223552 | ||
| Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun | Q73625506 | ||
| Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility | Q74205342 | ||
| Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy | Q80056726 | ||
| Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study | Q80160560 | ||
| The effects of rituximab treatment during pregnancy on a neonate | Q80236650 | ||
| The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment | Q80332339 | ||
| Maternal exposure to leflunomide associated with blindness and cerebral palsy | Q80548589 | ||
| Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study | Q81074699 | ||
| Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis | Q81077329 | ||
| Pregnancy outcome of women exposed to azathioprine during pregnancy | Q81230839 | ||
| Administration of rituximab during the first trimester of pregnancy without consequences for the newborn | Q82996883 | ||
| Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship | Q83230883 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 382-390 | |
| P577 | publication date | 2009-06-09 | |
| P1433 | published in | Nature Reviews Rheumatology | Q2107227 |
| P1476 | title | Management of RA medications in pregnant patients | |
| P478 | volume | 5 |
| Q39436705 | A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes |
| Q38996685 | A Review of the Course and Treatment of Non-Infectious Uveitis during Pregnancy |
| Q38659766 | A systematic review of interventions to improve knowledge and self-management skills concerning contraception, pregnancy and breastfeeding in people with rheumatoid arthritis |
| Q43576495 | Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma. |
| Q37927081 | Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. |
| Q83749416 | Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy |
| Q55054322 | Chronic pain during pregnancy: a review of the literature. |
| Q38131849 | Diagnosis, pathogenesis and treatment of myositis: recent advances |
| Q26859134 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update |
| Q37572053 | Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives |
| Q34577486 | Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study |
| Q38234725 | Glucocorticoids in myasthenia gravis - if, when, how, and how much? |
| Q37854742 | Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy |
| Q26744705 | Idiopathic Inflammatory Myopathies: Clinical Approach and Management |
| Q87866782 | Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era |
| Q38192051 | Inflammatory bowel disease in women of reproductive age. |
| Q28388274 | Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review |
| Q37215981 | Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis. |
| Q38594889 | Management of Hematologic Malignancies: Special Considerations in Pregnant Women |
| Q64276358 | Management of Inflammatory Arthritis in pregnancy: a National Cross-Sectional Survey of Canadian rheumatologists |
| Q26865914 | Management of inflammatory bowel disease in pregnancy |
| Q36548651 | Modulation of Endothelial Injury Biomarkers by Traditional Chinese Medicine LC in Systemic Lupus Erythematosus Patients Receiving Standard Treatments |
| Q90362329 | Oral corticosteroid use during pregnancy and risk of preterm birth |
| Q37991751 | Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers |
| Q41026313 | Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study |
| Q33894177 | Patterns of medication use during pregnancy in rheumatoid arthritis |
| Q87904759 | Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose |
| Q88289186 | Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database |
| Q28392552 | Pregnancy and Inflammatory Bowel Disease |
| Q44496562 | Pregnancy and inflammatory rheumatic diseases |
| Q38119553 | Reproduction and autoimmune disease: important translational implications from embryo-maternal interaction |
| Q36035301 | Reproductive trends in females with inflammatory joint disease |
| Q56656479 | Rheumatoid arthritis |
| Q35415687 | Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. |
| Q37943826 | Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management |
| Q30244019 | Rheumatoid arthritis. |
| Q38665700 | Safety profile of biological therapies for treating rheumatoid arthritis |
| Q37894193 | TNF alpha antagonist therapy and safety monitoring |
| Q34552050 | The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats |
| Q37814182 | The treatment of rheumatoid arthritis during pregnancy. |
| Q36866207 | Therapeutic interventions employed by Greater Toronto Area chiropractors on pregnant patients: results of a cross-sectional online survey |
| Q33601818 | Treating pain during pregnancy |
| Q35085907 | Treatment of acute abdominal pain in the emergency room: a systematic review of the literature. |
| Q38126540 | Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy |
| Q38832618 | Treatment of rheumatoid arthritis during pregnancy: present and future |
| Q35749182 | Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: A mixed-methods study |
| Q27691388 | Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis |
| Q34389362 | Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know |
| Q36446926 | Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia |
| Q87082709 | [DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain] |
Search more.